Skip to content

KLINISCH LABORATORIUM AZM

Active
Private limited companyfounded 1997active for 28 yearsNijverheidslaan 223A, 9250 Waasmunster, BelgiumKBO/BCE: BE 0462.308.136
Summary

KLINISCH LABORATORIUM AZM has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.6m and a net result of €170,276. Equity has been shrinking by about 7.2% per year since 2018. Its solvency ranks better than 31% of 3,033 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 31-12-1997 Normal situation
Activity
Medical imaging and medical laboratories NACE 86910
Joint committee
330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2025
Establishment units
2.222.920.987 2100 Antwerpen, since 19-12-1997
2.222.921.284 2018 Antwerpen, since 19-12-1997
Financial year end
31 December
Peppol
Reachable since 05-12-2025

Board and ownership

Board
  • JPS-60Director · since 04-07-2022 · permanent representative SION Jean-Paul Oscar Marie
Shareholders
  • CATAX2022 annual accounts of CATAX
  • JPS-602025 annual accounts of JPS-60

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€2.3m
Turnover
≈ €2.0m
estimated
Profit
€170,276
▲ 25.6%
Equity
€1.6m
▲ 11.7%
Total assets
€4.6m
▲ 10.8%
Employees on 31-12-2025
25
▼ 7.4%
Score breakdownlowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 17-07-2026)Liquidity: current ratio 1.40, cash €711,760Size: 21.8 FTE, total assets €4.6mShow the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 28% of small companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 60=
equity 35.4% of total assets
Liquidity 36+8
short-term debt 63.5% · cash 15.5%
Profitability 73+13
return on assets 3.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,080 companies, NACE 86, small)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €140,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.4 (1.33 in 2024), below the usual 1.5. Short-term debt is 63.5% and cash 15.5% of total assets. 64.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 18% of them on solvency, 6% on liquidity, 27% on profitability and 61% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Figures for financial year 2025 (filed on 17-07-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.40, cash €711,760
NBB · annual accounts
lowers risk · Size: 21.8 FTE, total assets €4.6m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.6m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
14 days early
2024
48 days early
2023
14 days early
2022
24 days late
2021
16 days early
2020
34 days late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 5 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (4 of the last 5 accounts filed within 34 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 4th largest company by total assets in Waasmunster, Health and social work…in the Checked rankings No. 4 View
  • Positive: 5 profitable years in a rowprofit 2025: €170,276 5 years View

Recent changes

  1. · Gazette deed 2 directors appointed, 3 directors resigningResignations: CATAX, SION Jean-Paul Oscar Marie and VERSTRAETE Roeland Jozef Frans Julius · Permanent representatives: COOREMAN Sarah Gwenn Robert Frida and SION Jean-Paul Oscar Marie · Appointments: CATAX (director) and JPS-60 (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as KLINISCH LABORATORIUM AZM: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €3.6m and €5.6m, founded between 1983 and 2004.

CompanyTotal assetsGross margin
KLINISCH LABORATORIUM AZM Waasmunster€4.6m€2.3m
RADIODIAGNOSE Gent€5.6m€2.4m
QUERCUS LABO Gent€4.5m€2.8m
Cerba Path Anderlecht€5.6m€2.1m
Département autonome de Diagnostic par Radio-isotopes Ukkel€3.6m€2.1m
R.D.I. - TEBACHE Limbourg€4.3m€1.9m
BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL Gent€3.7m€1.4m
Full comparison

Key facts about KLINISCH LABORATORIUM AZM

What is the company number of KLINISCH LABORATORIUM AZM?
The company number of KLINISCH LABORATORIUM AZM is 0462.308.136. The VAT number is the same number with BE in front: BE 0462.308.136.
Where is KLINISCH LABORATORIUM AZM based?
The registered office is at Nijverheidslaan 223A, 9250 Waasmunster.Company details
What does KLINISCH LABORATORIUM AZM do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of KLINISCH LABORATORIUM AZM?
The legal form of KLINISCH LABORATORIUM AZM is Private limited company (BV).
When was KLINISCH LABORATORIUM AZM founded?
KLINISCH LABORATORIUM AZM was founded on 31-12-1997.
Is KLINISCH LABORATORIUM AZM still active?
Yes, KLINISCH LABORATORIUM AZM is an active enterprise in the KBO register.
How many employees does KLINISCH LABORATORIUM AZM have?
KLINISCH LABORATORIUM AZM had an average of 21.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does KLINISCH LABORATORIUM AZM fall under?
In its 2025 annual accounts, KLINISCH LABORATORIUM AZM states joint committee 330.04 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of KLINISCH LABORATORIUM AZM?
The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €2.3m and 64 comparable companies (NACE 86). It probably lies between €1.9m and €3.0m. In financial year 2024 turnover was €10.6m.
Is KLINISCH LABORATORIUM AZM profitable?
In financial year 2025, KLINISCH LABORATORIUM AZM made a profit of €170,276.
Where can I find the annual accounts of KLINISCH LABORATORIUM AZM?
KLINISCH LABORATORIUM AZM filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KLINISCH LABORATORIUM AZM due?
KLINISCH LABORATORIUM AZM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.